Kelloff Gj - Concepedia

Author

Kelloff Gj

National Cancer Institute

Also Known As

G J Kelloff, GJ Kelloff, Kelloff Gj

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health IIT Research Institute

About

Kelloff Gj is an author at National Cancer Institute specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	259
2	Health Sciences	1	1	28
3	Cell Biology	1	1	28
4	Endocrinology	1	1	34
5	Immunology	1	1	13

Kelloff Gj

Publications

999

Citations

H-Index

Page 1

	Year	Citations
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy AD Barker, C C Sigman, Kelloff Gj, Clinical Pharmacology & Therapeutics	2009	740
Strategies for identification and clinical evaluation of promising chemopreventive agents. Kelloff Gj, Hawk Et, Crowell Ja, PubMed Chemopreventive AgentsChemoprevention StrategyMedicineIntermediate BiomarkersPharmacology	1996	55
Clinical development plan: N-(4-hydroxyphenyl)retinamide. Kelloff Gj, Crowell Ja, Boone Cw, PubMed Ocular DiseaseOphthalmologyMedicineClinical Development PlanPharmacotherapy	1994	39
Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone. Moon Rc, Steele Ve, Kelloff Gj, PubMed Breast OncologyChemoprevention StrategyTamoxifen CitrateGynecologyRu 16117	1994	34
Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia. Boone Cw, Kelloff Gj PubMed Clinical EndpointPathologyTumor BiologyOncologyTumor Heterogeneity	1994	28
The role of chemoprevention in cancer control. Peter Greenwald, Kelloff Gj PubMed OncologyChemopreventive Trial DesignsChemoprevention StrategyMedicineIntermediate Biomarkers	1996	28
Strategies for chemoprevention of prostate cancer Kelloff Gj, Ronald Lieberman, MK Brawer, Prostate Cancer and Prostatic Diseases UrologyChemoprevention StrategyMedicineProstatic DiseaseOncology	1999	26
Biomarker end-points in cancer chemoprevention trials. Boone Cw, Kelloff Gj PubMed Chemoprevention StrategyComputer-assisted Image AnalysisPathologyPharmacotherapyAnti-cancer Agent	1997	23
Oncogenic potential of murine C-type RNA virus passaged directly from naturally occurring tumors of the BALB-cCr mouse. Peters Rl, Spahn Gj, Rabstein Ls, PubMed Viral ReplicationImmunologyPathologyOncogenic PotentialVirology	1973	13
Animal models for chemoprevention of respiratory cancer. Moon Rc, Rao Kv, Detrisac Cj, PubMed Respiratory CancerChemoprevention StrategyOncogenic AgentMedicineLung Carcinogenesis	1992	13

Page 1